期刊文献+

乌司他丁治疗慢性阻塞性肺疾病急性加重疗效观察 被引量:2

下载PDF
导出
摘要 目的探讨乌司他丁治疗慢性阻塞性肺疾病急性加重(AECOPD)的临床效果。方法 40例AECOPD患者被随机分为对照组和乌司他丁组,每组20例。所有患者给予常规治疗,乌司他丁组在常规治疗基础上给予乌司他丁20万IU以20 mL生理盐水稀释后静脉推注,每8 h 1次。2组均治疗7 d。观察2组治疗前后呼吸频率(RR)、体温(T)、血白细胞(WBC)、C反应蛋白(CRP)、动脉血气相关指标以及APACHEⅡ评分变化。结果乌司他丁组RR、T、WBC、CRP、APACHEⅡ改善情况均明显优于对照组(P均<0.05);治疗7 d后,2组的T、RR、CRP、p(CO2)均下降,p(O2)升高,乌司他丁组的疗效优于对照组(P<0.05)。结论在传统常规治疗AECOPD基础上联用乌司他丁可有效改善病情,降低各项炎症指标,保护重要脏器功能。
作者 强树华
出处 《现代中西医结合杂志》 CAS 2013年第8期884-885,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献7

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 3谢灿茂,周宇麒.慢性阻塞性肺疾病急性加重的诊断与治疗新进展[J].中华结核和呼吸杂志,2005,28(5):346-348. 被引量:80
  • 4兰岚,高占成.慢性阻塞性肺疾病急性加重的发病机制[J].国际呼吸杂志,2007,27(3):203-206. 被引量:24
  • 5American thoracic society. Guidelines for themanagement of adultswith community acquired pneumonia diagnosis,assessment of severi-ty ,antimicrobial therapy, and prevention [ J ]. Am J Respir CritCare Med ,2001,163 (7) :1730 - 1754.
  • 6Pugia MJ, Valdes R, Jortani SA. Bikunin ( urinary tyrpsin inhibi-tor) :structure, biological relevance, and measurement [ J ]. Ad-vances in Clinical chemistry, 2007 ,44 : 224 - 240.
  • 7Mizon C,Piva F, Queyrel V , et al. Uinary bikunin determinationprovides insight into proteinase/proteinase inhibitor imbalance inpatients with inflammatory diseases[ J]. Clin Chem Lab Med ,2002 ,40(6) :579 -586.

二级参考文献46

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Supp1,2003,41:46s-53s.
  • 3Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
  • 4Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.
  • 5Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
  • 6Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2) :398SM01S.
  • 7Snow V, Lascher S, Mottur-Pilson C, et al.Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med ,2001,134.595-599.
  • 8Panwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J ResDir Crlt Care Med ,2001,163:1256-1276.
  • 9Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J ,2004,23:932-946.
  • 10MacNee W. Acute exacerbations of COPD. Swiss Med Wkly,2003,133:247-257.

共引文献11057

同被引文献21

  • 1姚尚龙,张诗海,徐尤年.ALI/ARDS发病机制与治疗进展[J].中国继续医学教育,2011,3(10):63-77. 被引量:14
  • 2景炳文.乌司他丁在急危重症临床应用的进展[J].中国危重病急救医学,2006,18(2):117-120. 被引量:127
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1790
  • 4Niederman MS, Mandell LA, Anzueto A, et al. Guide- lines for the management of adults with community-ac- quired pneumonia diagnosis, assessment of severity, an- timicrobial therapy, and prevention [J]. Am J Respir Crit Care Med, 2001,163 (7):1730-1754.
  • 5Aoshiba K. Roles of apoptosis, cell senescence and DNA damage in the pathogenetic mechanism of COPD [J]. Ni- hon Rinsho, 2011,69(10) : 1754-1757.
  • 6Barros e Silva PG,Califf RM,Sun JL,et al. Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial[J]. Int J Cardiol, 2014,176 (3) : 1126-1128.
  • 7Li G,Li T,Li Y,et al. Ulinastatin inhibits oxidant-induced en- dothelial hyperpermeability and apoptotic signaling[J]. Int J Clin Exp Pathol, 2014,7 ( 11 ) : 7342-7350.
  • 8Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease:definition,assessment,and prevention[J]. Lancet,2015,385 (9979) : 1778-1788.
  • 9Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD-implications and relevance for treatment[J]. Int J Chron Obstruct Pulmon Dis ,201d, 17(9) : 1207-1224.
  • 10李晓亮,向小勇,陈力,沈学远,洪斌.TNF-α、PAF、IL-10在急性肺损伤患者血清中的变化及意义[J].重庆医科大学学报,2009,34(6):772-774. 被引量:19

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部